What’s new in the management of adult bronchiectasis? [version 1; referees: 2 approved]

Abstract

Bronchiectasis is a heterogeneous, chronic condition with many aetiologies. It poses a significant burden on patients and healthcare practitioners and services. Clinical exacerbations often result in reduced quality of life, increased rate of lung function decline, increased hospitalisation, and mortality. Recent focus in respiratory research, guidelines, and future management options has improved this clinical field in evidence-based practice, but further work and phase III clinical trials are required. This article aims to summarise and explore advances in management strategies in recent years and highlight areas of research and future focus.

Keywords

• Bacterial Infections
• COPD & Allied Disorders
• Epidemiology
• Respiratory Infections
• Respiratory Pediatrics
• Respiratory Pharmacology